Moleculin Biotech (MBRX) Leases (2018 - 2025)
Moleculin Biotech's Leases history spans 8 years, with the latest figure at $314000.0 for Q4 2025.
- Quarterly results put Leases at $314000.0 for Q4 2025, down 25.94% from a year ago — trailing twelve months through Dec 2025 was $314000.0 (down 25.94% YoY), and the annual figure for FY2025 was $314000.0, down 25.94%.
- Leases for Q4 2025 was $314000.0 at Moleculin Biotech, down from $343000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $547000.0 in Q3 2023 to a low of $81000.0 in Q1 2022.
- The 5-year median for Leases is $389500.0 (2023), against an average of $350550.0.
- The sharpest move saw Leases tumbled 54.75% in 2022, then soared 370.37% in 2023.
- Year by year, Leases stood at $107000.0 in 2021, then surged by 276.64% to $403000.0 in 2022, then skyrocketed by 30.02% to $524000.0 in 2023, then dropped by 19.08% to $424000.0 in 2024, then decreased by 25.94% to $314000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $314000.0, $343000.0, and $370000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.